Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
life sciences
boston
boston blog main
boston top stories
clinical trials
dna
genetics
national blog main
tc
23andme
ally bridge group
belgian startups
big data analytics
biology
biotech ipos
biotechnology
blackrock
california
cambridge
casdin capital
crispr
diabetic nephropathy
disease
dyne therapeutics
emerging-technologies
eventide asset management
extreme
fda
features
focal segmental glomerulosclerosis
free
fundings & exits
genetic testing
genomic analysis
genoox
george church
globachem
goldfinch bio
harvard university
What
genetic
8
×
million
8
×
raised
company
data
medical
analysis
medicine
new
raises
startup
agriculture
andme
develop
developing
drug
investment
ipo
make
medicines
patient
precision
reports
that’s
accessible
agreement
americans
ancestry
announced
appeared
applications
awarded
belgian
belonging
big
bio
biology
biostrand
biotech
biotechnology
Language
unset
Current search:
million
×
genetic
×
@xconomy.com
4 years ago
Dyne’s Upsized IPO Brings In $233M for Muscle Disorders Drug R&D
@xconomy.com
4 years ago
Goldfinch Raises $100M for Kidney Drug Studies Now, Perhaps an IPO Later
@tech.eu
4 years ago
Belgian startup BioStrand raises €2 million to disrupt genetic data analysis
@techcrunch.com
5 years ago
DNA Script picks up $38.5 million to make DNA production faster and simpler
@extremetech.com
6 years ago
23andMe, Michael J. Fox Foundation to Study Genetic Factors of Parkinson’s
@techcrunch.com
7 years ago
Genoox raises $6M to make genetic data analysis more accessible for clinics
@theverge.com
9 years ago
White House unveils $215 million plan to develop patient-specific medical treatments
@theverge.com
9 years ago
23andMe to offer users' medical data to Pfizer for research